FN3KRP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.347800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.043600E-01
Normal-vs-Stage2
6.461200E-01
Normal-vs-Stage3
7.603200E-01
Normal-vs-Stage4
6.679700E-02
Stage1-vs-Stage2
4.469400E-01
Stage1-vs-Stage3
7.554600E-01
Stage1-vs-Stage4
4.642100E-02
Stage2-vs-Stage3
3.416400E-01
Stage2-vs-Stage4
2.996800E-01
Stage3-vs-Stage4
1.440170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.485600E-01
Normal-vs-AfricanAmerican
5.580800E-01
Normal-vs-Asian
6.732600E-01
Caucasian-vs-AfricanAmerican
5.933400E-01
Caucasian-vs-Asian
9.330400E-01
AfricanAmerican-vs-Asian
5.878600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.339800E-01
Normal-vs-Female
5.355800E-01
Male-vs-Female
1.418650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.974400E-01
Normal-vs-Age(41-60Yrs)
3.147400E-01
Normal-vs-Age(61-80Yrs)
8.115600E-01
Normal-vs-Age(81-100Yrs)
4.886400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.75520000042806E-07
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.380270E-03
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.489760E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.490150E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.529800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.436800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.670400E-01
Normal-vs-Daily Drinker
6.628400E-01
Normal-vs-Weekly Drinker
6.921800E-01
Normal-vs-Occasional Drinker
3.900800E-01
Normal-vs-Social Drinker
5.813400E-01
Non Drinker-vs-Daily Drinker
7.774400E-01
Non Drinker-vs-Weekly Drinker
2.018800E-01
Non Drinker-vs-Occasional Drinker
2.886200E-01
Non Drinker-vs-Social Drinker
9.424000E-01
Daily Drinker-vs-Weekly Drinker
1.377820E-01
Daily Drinker-vs-Occasional Drinker
4.457600E-01
Daily Drinker-vs-Social Drinker
8.079400E-01
Weekly Drinker-vs-Occasional Drinker
2.455600E-02
Weekly Drinker-vs-Social Drinker
1.221990E-01
Occasional Drinker-vs-Social Drinker
2.912000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.598760E-01
Normal-vs-Grade 2
7.816300E-02
Normal-vs-Grade 3
9.522200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.966400E-01
Grade 1-vs-Grade 3
4.806600E-01
Grade 1-vs-Grade 4
1.598760E-01
Grade 2-vs-Grade 3
8.673200E-01
Grade 2-vs-Grade 4
7.816300E-02
Grade 3-vs-Grade 4
9.522200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.007400E-01
Normal-vs-NonDiabetic
5.492200E-01
Diabetic-vs-NonDiabetic
4.910400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.717800E-01
Normal-vs-NoPancreatitis
6.760400E-01
Pancreatitis-vs-NoPancreatitis
2.547200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.078800E-01
Normal-vs-N1
6.496200E-01
N0-vs-N1
9.328600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.969800E-01
Normal-vs-TP53-NonMutant
7.883800E-01
TP53-Mutant-vs-TP53-NonMutant
6.638600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
